Endocrine, metabolic, blood, and immune disorders ( EMBID ) constitute a significant and growing burden worldwide, with 79.47 million new cases reported in 2021 alone. While incidence and prevalence rates show slight declines globally, mortality and disability-adjusted life years (DALYs) related to these disorders continue to rise, particularly among older adults. Women generally exhibit higher incidence and prevalence, whereas men experience higher mortality. Regional disparities reveal that lower Socio-demographic Index (SDI) regions shoulder a disproportionate burden, aggravated by limited healthcare access.
Projections to 2050 underscore the urgency for tailored public health interventions, especially in low-resource settings, to mitigate the escalating impacts of EMBID. To learn more — click here . ##Reference## Liang Y, Leng Y, Bai W, et al. Global, regional, and national burden…
